Dr. Shiraj Sen is a medical oncologist and director of NEXT Oncology Dallas. Meeting some of the first individuals with cancer treated on modern immunotherapy clinical trials and watching them feel better and live longer after being told that there were no further standard treatments for them to receive motivated him to pursue a career in drug development in order to continue bringing the newest treatments to individuals with cancer. As a native Texan, Dr. Sen calls NEXT Oncology a perfect fit for him both personally and professionally as it allows him to serve his community and provide compassionate care while developing new treatments against cancer and offering them to his patients if standard treatments are no longer helping.
BACKGROUND
Dr. Sen received his undergraduate degree from the University of Texas at Austin and his MD and PhD degrees from the University of Texas at Houston and MD Anderson Cancer Center Graduate School of Biomedical Sciences. His post graduate training in internal medicine was performed at the University of Texas Southwestern Medical Center in Dallas prior to completing his hematology and medical oncology fellowship at the University of Texas MD Anderson Cancer Center.
Dr. Sen is Board Certified in Internal Medicine and Medical Oncology and is the recipient of numerous awards for his research such as the Waun Ki Hong Award for Achievement in Clinical Investigation, the Marion D. Edwards Fellowship in Hepatic Oncology, and the American Society of Clinical Oncology (ASCO) Conquer Cancer Foundation merit award. He has also authored more than 30 peer-reviewed publications, presented his research at over 20 international conferences, and has served as a member of the ASCO Scientific Program Committee.